Persones / Equip Humà

Ignacio Aznar Lou

Buscador de publicacions

Publicacions

  • Fuente M, Cahir C, Passos VL, Bennett K, Walsh C, Hermida-González P, Peláez de Loño J, Abella MER, Baladon L, Rubio-Valera M, Serrano-Blanco A and Aznar I.

    Identifying longitudinal medication adherence patterns of antipsychotic treatments: A real-world cohort study in Catalonia, Spain

    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . : . Nº de cites: 1

    [doi:10.1111/bcp.16399]

  • Vargas I, Mogollón-Pérez AS, Eguiguren P, Torres AL, Peralta A, Rubio-Valera M, Jervelund SS, Borras JM, Dias S and Vázquez ML.

    Understanding the health system drivers of delayed cancer diagnosis in public healthcare networks of Chile, Colombia and Ecuador: A qualitative study with health professionals, managers and policymakers.

    SOCIAL SCIENCE & MEDICINE . 365: 117499-117499.

    [doi:10.1016/j.socscimed.2024.117499]

  • Soler M, Ribera A, Aznar I, Sanchez A, Slof J, Vela E, Salvat-Plana M, Villa-García L, Serrano-Blanco A, Pérez de la Osa N, Ribó M and Abilleira S.

    Costs during the first year after stroke by degree of functional disability: A societal perspective

    European Stroke Journal . 10(2): 513-523.

    [doi:10.1177/23969873241301904]

  • Peña C, Kazah N, Carrillo B, Díaz C, Callen A, Serrano-Blanco A and Aznar I.

    Comorbilidad neurológica en pacientes psiquiátricos ingresados: evidencia sobre interconsultas de neurología en un centro español.

    REVISTA DE NEUROLOGIA . 79(1): 11-20. Nº de cites: 1

    [doi:10.33588/rn.7901.2024054]

  • Fuente M, Dima AL, Rubio-Valera M, Baladon L, Chavarría V, Fabrizio S, Peña C, Serra-Sutton V, Hermida-González P, de Loño JP, Rey-Abella ME, Aznar I and Serrano-Blanco A.

    Evaluation of adherence to antipsychotics: A real-world data study using four different dosing assumptions

    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . 90(6): 1480-1492. Nº de cites: 2

    [doi:10.1111/bcp.16042]

  • Vázquez ML, Vargas I, Rubio-Valera M, Aznar I, Eguiguren P, Mogollón-Pérez AS, Torres AL, Peralta A, Dias S and Jervelund SS.

    Improving equity in access to early diagnosis of cancer in different healthcare systems of Latin America: protocol for the EquityCancer-LA implementation-effectiveness hybrid study.

    BMJ Open . 12(12): . Nº de cites: 5

    [doi:10.1136/bmjopen-2022-067439]

  • Corral C, Sanchez A, Gil MM, Peñarrubia-María MT, Aznar I, Serrano-Blanco A, Carbonell-Duacastella C, Gallardo MC, Mari Carmen Olmos Palenzuela and Rubio-Valera M.

    Improving Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care: Pilot trial of a complex intervention.

    Frontiers in public health . 10: 1038138-1038138. Nº de cites: 6

    [doi:10.3389/fpubh.2022.1038138]

  • Soler M, Aznar I, Basile L, Soldevila N, Godoy P, Martínez A, Serrano-Blanco A, Domínguez A and The Surveillance of Hospitalized Cases of Severe Influenza in Catalonia Working.

    Costs and Factors Associated with Hospitalizations Due to Severe Influenza in Catalonia (2017-2020).

    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH . 19(22): 14793. Nº de cites: 3

    [doi:10.3390/ijerph192214793]

  • Corral C, Sanchez A, Gil MM, Peñarrubia-María MT, Aznar I, Gallardo MC, Mari Carmen Olmos Palenzuela and Rubio-Valera M.

    Complex multidisciplinary intervention to improve Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care (the IMA-cRCT study): mixed-methods process evaluation protocol.

    BMJ Open . 12(10): . Nº de cites: 4

    [doi:10.1136/bmjopen-2022-067468]

  • Peñarrubia-María MT, Sanchez A, Corral C, Gallardo MC, Mari Carmen Olmos Palenzuela, Fernández-Vergel R, Mendive JM, Gil MM, Aznar I and Rubio-Valera M.

    Impacte clínic i econòmic de la no iniciació dels tractaments de prevenció primària de malalties cardiovasculars

    Butlletí de l'Atenció Primària de Catalunya . 40(4): 1-9.